Shareholders' Equity (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 2 Months Ended | 12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 06, 2020 |
Jun. 10, 2020
$ / shares
shares
|
Mar. 09, 2020
USD ($)
$ / shares
shares
|
Feb. 10, 2020
$ / shares
shares
|
Jan. 09, 2020
USD ($)
$ / shares
shares
|
May 10, 2019 |
Apr. 04, 2019
USD ($)
$ / shares
shares
|
Apr. 28, 2020
₪ / shares
shares
|
Dec. 31, 2019
₪ / shares
shares
|
Sep. 30, 2019
shares
|
May 22, 2019
USD ($)
$ / shares
shares
|
Jan. 18, 2019
USD ($)
$ / shares
shares
|
Nov. 28, 2013
₪ / shares
shares
|
May 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
shares
|
Dec. 31, 2019
USD ($)
shares
|
Dec. 31, 2018
USD ($)
shares
|
Dec. 31, 2020
₪ / shares
shares
|
|
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Stockholders equity change In ratio description | (1) ADS representing two (2) ordinary shares to a new ratio of one (1) ADS representing thirty (30) ordinary shares. For ADS holders, the ratio change had the same effect as a one-for-fifteen reverse ADS split. All ADS and per ADS data in the financial statements and their related notes have been retroactively adjusted for all periods presented to reflect the ratio change. | |||||||||||||||||
| Ordinary shares issued | 20,250,000 | 996,690 | 19,934,355 | 31,000,020 | ||||||||||||||
| Aggregate purchase price (in Dollars) | $ | $ 3,200 | $ 6,000 | $ 2,350 | |||||||||||||||
| Issuance cost (in Dollars) | $ | $ 414 | $ 540 | $ 428 | |||||||||||||||
| Ordinary shares issued | 30 | |||||||||||||||||
| Aggregate shares | 22,278,540 | |||||||||||||||||
| Reduced exercise price (in Dollars per share) | $ / shares | $ 3.25 | |||||||||||||||||
| Issue of new unregistered warrants | 22,278,540 | |||||||||||||||||
| Deemed dividend (in Dollars) | $ | $ 715 | |||||||||||||||||
| Securities purchase agreement, description | the Company entered into a Securities Purchase Agreement with certain institutional investors pursuant to which the Company issued and sold (i) 1,825,000 units, each unit consisting of one ADS, and one warrant to purchase one ADS, at a price of USD 1.50 per unit, and (ii) 1,508,334 pre-funded units each pre-funded unit consisting of one pre-funded warrant to purchase one ADS and one warrant, at a price of USD 1.49 per pre-funded unit. The offering of the units and pre-funded units closed on February 12, 2020. | |||||||||||||||||
| Gross proceeds (in Dollars) | $ | $ 1,012 | $ 1,550 | $ 75 | $ 115 | $ 282 | |||||||||||||
| Increase authorized capital | 1,000,000,000 | |||||||||||||||||
| Par value (in New Shekels per share) | ₪ / shares | ₪ 0.25 | ₪ 0.25 | ₪ 0.25 | |||||||||||||||
| Stock issuance agreement, description | the Company entered into a definitive agreement with certain institutional and accredited investors providing for the issuance of an aggregate of 1,705,000 ADSs in a registered direct offering at a purchase price of $2.00 per ADS for aggregate gross proceeds of approximately $3,400 prior to deducting the placement agent’s fees and estimated offering expenses payable by the Company. In addition, in a concurrent private placement, the investors received unregistered warrants to purchase up to an aggregate of 852,750 ADSs. The warrants were immediately exercisable and will expire four and a half years from issuance at an exercise price of $2.50 per ADS, subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants. The placement agent in the offering also received compensation warrants on substantially the same terms as the investors in the offering in an amount equal to 7.5% of the aggregate number of ADSs sold in the offering (or warrants to purchase up to an aggregate of 127,913 ADSs), at an exercise price of $2.50 per ADSs and a term expiring. | the Company entered into a definitive agreement with certain institutional and accredited investors providing for the issuance of an aggregate of 3,902,440 ADSs in a registered direct offering at a purchase price of $2.05 per ADS for aggregate gross proceeds of approximately $8,000 prior to deducting the placement agent’s fees and estimated offering expenses payable by the Company. | ||||||||||||||||
| Aggregate number of ADS percentage | 7.50% | |||||||||||||||||
| Exercise price per ADS (in Dollars per share) | $ / shares | $ 2.50 | |||||||||||||||||
| Issue of ordinary shares consultant in exchange for services | 1,350,000 | |||||||||||||||||
| Share option terms | 10 years | |||||||||||||||||
| Expiring date | Feb. 10, 2025 | |||||||||||||||||
| 2013 Share Option Plan [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Ordinary shares issued | 2,500,000 | |||||||||||||||||
| Par value (in New Shekels per share) | ₪ / shares | ₪ 0.25 | |||||||||||||||||
| Ordinary shares reserved for issuance | 25,000,000 | |||||||||||||||||
| Shares available for future grant | 13,225,000 | |||||||||||||||||
| ADS [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Sold an aggregate shares | 328,205 | 1,500,000 | 149,206 | |||||||||||||||
| Ordinary shares issued | 675,000 | 1,033,334 | ||||||||||||||||
| Warrants to purchase additional shares | 149,206 | |||||||||||||||||
| Warrant exercise price (in Dollars per share) | $ / shares | $ 19.50 | |||||||||||||||||
| Purchase aggregate warrant | 328,205 | 1,500,000 | 7,460 | |||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 2.50 | $ 1.875 | $ 12.90 | $ 4.00 | ||||||||||||||
| Aggregate warrant purchased | 292,683 | 16,410 | 75,000 | |||||||||||||||
| Aggregate shares | 742,618 | |||||||||||||||||
| Issue of new unregistered warrants | 1,951,220 | |||||||||||||||||
| Exercise price subject to adjustment (in Dollars per share) | $ / shares | $ 3.45 | |||||||||||||||||
| Compensation warrant exercisable | 250,000 | |||||||||||||||||
| Share price (in Dollars per share) | $ / shares | $ 1.50 | $ 1.50 | ||||||||||||||||
| ADS [Member] | Minimum [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | 12.90 | |||||||||||||||||
| ADS [Member] | Maximum [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Exercise prices (in Dollars per share) | $ / shares | $ 78.75 | |||||||||||||||||
| ADS [Member] | Private Placement Warrants [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Issue of new unregistered warrants | 742,618 | |||||||||||||||||
| Ordinary Shares [Member] | ||||||||||||||||||
| Shareholders' Equity (Details) [Line Items] | ||||||||||||||||||
| Sold an aggregate shares | 9,846,156 | |||||||||||||||||
| Ordinary shares issued | 9,846,156 | 45,000,000 | 4,476,192 | 1,350,000 | 996,690 | 437,000 | ||||||||||||
| Warrants to purchase additional shares | 4,476,192 | |||||||||||||||||
| Ordinary shares issued | 492,308 | 45,000,000 | 223,810 | |||||||||||||||
| Ordinary shares issued | 2,250,000 | |||||||||||||||||
| Gross proceeds (in Dollars) | $ | $ 100 | $ 72 | $ 30 | |||||||||||||||